Genetic aspects and research development in haemostasis

Haemophilia

Volumn 14, Issue SUPPL. 3, 2008, Pages 113-118

  Tuddenham, E G ^a   Ingerslev, J ^b   Norengaard Sorensen L ^b   Christiansen, K ^b   Mariani, G ^b   Peyvandi, F ^c   Waddington, S N ^a   Buckley, S M K ^a   Kochanek, S ^a   Chuah, M K ^c   Vandendriessche, T ^d   Berntorp, E ^d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MILAN   (Italy)

^d University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBRINOGEN; INTERLEUKIN 10; PROTHROMBIN;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; DNA POLYMORPHISM; FAMILY STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HEMOGLOBIN BLOOD LEVEL; HEMOPHILIA B; HEMOSTASIS; HUMAN; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PREVALENCE; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

BLOOD COAGULATION FACTOR INHIBITORS; COHORT STUDIES; FACTOR VII; FACTOR VII DEFICIENCY; GENE THERAPY; HEMOSTASIS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 44249105414     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01740.x     Document Type: Article

References (19)

1. Mariani G, Herrmann F, Dolce A, Batorova A, Etro D et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-7.
2. Nicolajsen EM, Hansen LL, Poulsen F, Glazer S, Hedner U. Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use. Thromb Haemost 1996; 76: 200-4.
3. Ingerslev J, Christiansen K, Sørensen B. Inhibitor to factor VII in severe factor VII deficiency: Detection and course of the inhibitory response. J Thromb Haemost 2005; 3: 799-800.
4. Batorova A, Mariani G, Ingerslev J, Schwed J-F, Auerswald G et al. Inhibitor in congenital severe factor VII deficiency (Abstract). Presented at the XXIst Congress of the International Society on Thrombosis and Haemostasis 2007. Abstract P-S-165.
5. Tuddenham EGD, Cooper DN. The Molecular Genetics of Haemostasis and Its Inherited Disorders. Oxford, UK: Oxford Medical Publications, 1994. Oxford Monography on Medical Genetics No. 25.
6. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-21.
7. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
8. Zhang B, Cunningham MA, Nichols WC, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet. 2003; 34: 220-5.
9. Sadler JE. Medicine: K for koagulation. Nature 2004; 427: 493-4.
10. Dewerchin M, Liang Z, Moons L, Carmeliet P, Castellino FJ, Collen D, Rosen ED. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost. 2000; 83: 185-90.
11. Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmbäck K, Xiao Q, Bugge TH, Degen SJ. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 1998; 95: 7597-602.
12. Waddington SN, Nivsarkar M, et al. Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy. Blood 2004; 104: 2714-21.
13. Lipshutz GS, Sarkar R, et al. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Proc Natl Acad Sci USA 1999; 96: 13324-9.
14. Nilsson IM, Berntorp E, Rickard KA. Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmömodel. Haemophilia 1995; 1: 59-66.
15. Astermark J, Berntorp E, White GC, Kroner BL, the MIBS Study Group. The MalmöInternational Brother Study (MIBS): Further support for genetic predisposition to inhibitor development in hemophilia patients. Haemophilia 2001; 7: 267-72.
16. Astermark J, Oldenburg J, Escobar M, White GC 2nd, Berntorp E, the MalmöInternational Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A. Haematologica 2005; 90: 924-31.
17. Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK, the MIBS Study Group. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood 2006a; 107: 3167-72.
18. Astermark J, Oldenburg J, Carlson J, Pavlova A, Kavakli K, Berntorp E, Lefvert AK. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood 2006b; 108: 3739-45.
19. Astermark J, Wang X, Oldenburg J, Berntorp E, Lefvert AK for the MIBS Study Group. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J Thromb Haemost 2007; 5: 263-5.